Without affordable medications for weight loss and AI-powered behaviour change, we risk bankrupting the US healthcare system. The market opportunity for GLP-1s in the US continues to grow, with expectations that it exceeds US$100 billion with 30 million total users by 2030
Seguimiento mnimo de 104 semanas
Building a support system of friends, family, or professionals encourages accountability and reduces feelings of isolation during lifestyle changes
Interestingly, many of these benefits appear independent of weight loss alone
Se trata de los primeros datos en personas que demuestran que los GLP-1 pueden afectar la supervivencia del CDIS, dijo el presentador del pster Danish Safi, MD, onclogo mdico de la Universidad de Virginia Occidental
Reputation and customer feedback Customer experiences with MedVi are mixed